Protalix BioTherapeutics Current Ratio 1970-1969 | PLX
Protalix BioTherapeutics current ratio from 1970 to 1969. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
|Protalix BioTherapeutics Current Ratio Historical Data
||Medical - Biomedical and Genetics
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.